Antimicrobial and antifouling efficacy of urinary catheters impregnated with a combination of macrolide and fluoroquinolone antibiotics against Pseudomonas aeruginosa

References

• Ashraf W, Bayston R, Stevenson O. 2010. The development of an antimicrobial EVD catheter to protect against multi-resistant hospital “superbugs”. Cerebrospinal Fluid Res. 7:S46–S46. doi:10.1186/1743-8454-7-S1-S46
   Google Scholar
• Bala A, Kumar R, Harjai K. 2011. Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections. J Med Microbiol. 60:300–306. doi:10.1099/jmm.0.025387-0
   PubMed Web of Science ®Google Scholar
• Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. 1989. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 52:605–609. doi:10.1136/jnnp.52.5.605
   PubMed Web of Science ®Google Scholar
• Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. 2011. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother. 55:2655–2661. doi:10.1128/AAC.00045-11
   PubMed Web of Science ®Google Scholar
• Buyck JM, Plésiat P, Traore H, Vanderbist F, Tulkens PM, Van Bambeke F. 2012. Increased Susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. Clin Infect Dis. 55:534–542. doi:10.1093/cid/cis473
   PubMed Web of Science ®Google Scholar
• CDC. 2012. Device- associated module: catheter associated urinary tract infection event. Available from http://wwwcdcgov/nhsn/pdfs/pscmanual/7psccauti-currentpdf.
   Google Scholar
• Chaiban G, Hanna H, Dvorak T, Raad I. 2005. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. J Antimicrob Chemother. 55:51–56.
   PubMed Web of Science ®Google Scholar
• Darouiche RO, Raad I, inventors. 1997. Antimicrobial impregnated catheters and other medical implants and a method for impregnating catheters and other medical implants with an antimicrobial agent. US Patent. 5624704 A.
   Google Scholar
• Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA. 2005. Bacterial interference for prevention of urinary tract infection: a prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis. 41:1531–1534. doi:10.1086/497272
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 15:167–193. doi:10.1128/CMR.15.2.167-193.2002
   PubMed Web of Science ®Google Scholar
• El-Rehewy MSK, El-Feky MA, Hassan MA, Abolella HA, Abolyosr A, El-Baky RMA, Gad GF. 2009. In vitro efficacy of ureteral catheters impregnated with ciprofloxacin, N-acetylcysteine and their combinations on microbial adherence. Clin Med Insights Urol. 3:1–8.
   Google Scholar
• Fisher LE. 2011. Development and evaluation of an antimicrobial urinary catheter [thesis]. Nottingham: University of Nottingham.
   Google Scholar
• Fisher LE, Hook AL, Ashraf W, Yousef A, Barrett DA, Scurr DJ, Chen X, Smith EF, Fay M, Parmenter CDJ, et al. 2015. Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity. J Control Release. 202:57–64. doi:10.1016/j.jconrel.2015.01.037
   PubMed Web of Science ®Google Scholar
• Gaonkar TA, Sampath LA, Modak SM. 2003. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infect Control Hosp Epidemiol. 24:506–513. doi:10.1086/iche.2003.24.issue-7
   PubMed Web of Science ®Google Scholar
• Guiton PS, Hung CS, Hancock LE, Caparon MG, Hultgren SJ. 2010. Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect Immun. 78:4166–4175. doi:10.1128/IAI.00711-10
   PubMed Web of Science ®Google Scholar
• Hachem R, Reitzel R, Borne A, Jiang Y, Tinkey P, Uthamanthil R, Chandra J, Ghannoum M, Raad I. 2009. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother. 53:5145–5149. doi:10.1128/AAC.00718-09
   PubMed Web of Science ®Google Scholar
• Hamill TM, Gilmore BF, Jones DS, Gorman SP. 2007. Strategies for the development of the urinary catheter. Expert Rev Med Devic. 4:215–225. doi:10.1586/17434440.4.2.215
   PubMed Web of Science ®Google Scholar
• Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, Raad I. 2006. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 50:3283–3288. doi:10.1128/AAC.01622-05
   PubMed Web of Science ®Google Scholar
• Harding GKM, Zhanel GG, Nicolle LE, Cheang M. 2002. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 347:1576–1583. doi:10.1056/NEJMoa021042
   PubMed Web of Science ®Google Scholar
• Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Sanjay S, Anthony JS, Paul AT, Peter T, et al. 2010. Diagnosis, prevention, and treatment of catheter-aassociated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis. 50:625–663. doi:10.1086/650482
   PubMed Web of Science ®Google Scholar
• Imamura Y, Higashiyama Y, Tomono K, Izumikawa K, Yanagihara K, Ohno H, Miyazaki Y, Hirakata Y, Mizuta Y, J-i Kadota, et al. 2005. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob Agents Chemother. 49:1377–1380. doi:10.1128/AAC.49.4.1377-1380.2005
   PubMed Web of Science ®Google Scholar
• Johnson JR, Kuskowski MA, Wilt TJ. 2006. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med. 144:116–126. doi:10.7326/0003-4819-144-2-200601170-00009
   PubMed Web of Science ®Google Scholar
• Johnson JR, Johnston B, Kuskowski MA. 2012. In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms. Antimicrob Agents Chemother. 56:4969–4972. doi:10.1128/AAC.00733-12
   PubMed Web of Science ®Google Scholar
• Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 130:797–810. doi:10.1016/j.cell.2007.06.049
   PubMed Web of Science ®Google Scholar
• Kumar R, Chhibber S, Gupta V, Harjai K. 2011. Screening & profiling of quorum sensing signal molecules in Pseudomonas aeruginosa isolates from catheterized urinary tract infection patients. Indian J Med Res. 134:208–213.
   PubMed Web of Science ®Google Scholar
• Maki DG, Tambyah PA. 2001. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 7:342–347. doi:10.3201/eid0702.010240
   PubMed Web of Science ®Google Scholar
• Makuta G, Chrysafis M, Lam T. 2013. Measuring the efficacy of antimicrobial catheters. Nurs Times. 109:16–19.
   PubMedGoogle Scholar
• Montenez JP, Van Bambeke F, Piret J, Brasseur R, Tulkens PM, Mingeot-Leclercq MP. 1999. Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. Toxicol Appl Pharmacol. 156:129–140. doi:10.1006/taap.1999.8632
   PubMed Web of Science ®Google Scholar
• Park JH, Cho YW, Cho YH, Choi JM, Shin HJ, Bae YH, Chung H, Jeong SY, Kwon IC. 2003. Norfloxacin-releasing urethral catheter for long-term catheterization. J Biomater Sci Polym Ed. 14:951–962. doi:10.1163/156856203322381438
   PubMed Web of Science ®Google Scholar
• Preston CAK, Khoury AE, Reid G, Bruce AW, Costerton JW. 1996. Pseudomonas aeruginosa biofilms are more susceptible to ciprofloxacin than to tobramycin. Int J Antimicrob Agents. 7:251–256. doi:10.1016/S0924-8579(96)00330-5
   PubMed Web of Science ®Google Scholar
• Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY. 2012. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother. 56:935–941. doi:10.1128/AAC.05836-11
   PubMed Web of Science ®Google Scholar
• Saini H, Chhibber S, Harjai K. 2015. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. Int J Antimicrob Agents. 45:359–367. doi:10.1016/j.ijantimicag.2014.11.008
   PubMed Web of Science ®Google Scholar
• Schumm K, Lam TBL. 2008. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Db Syst Rev. 2:CD004013. doi: 10.1002/14651858
   Google Scholar
• Siddiq DM, Darouiche RO. 2012. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol. 9:305–314. doi:10.1038/nrurol.2012.68
   PubMed Web of Science ®Google Scholar
• Tateda K, Comte R, Pechere JC, Köhler T, Yamaguchi K, Van Delden C. 2001. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 45:1930–1933. doi:10.1128/AAC.45.6.1930-1933.2001
   PubMed Web of Science ®Google Scholar
• Vadekeetil A, Alexandar V, Chhibber S, Harjai K. 2016. Adjuvant effect of cranberry proanthocyanidin active fraction on antivirulent property of ciprofloxacin against Pseudomonas aeruginosa. Microb Pathog. 90:98–103. doi:10.1016/j.micpath.2015.11.024
   PubMed Web of Science ®Google Scholar
• Wu H, Moser C, Wang H-Z, Hoiby N, Song Z-J. 2015. Strategies for combating bacterial biofilm infections. In J Oral Sci. 7:1–7. doi:10.1038/ijos.2014.65
   Web of Science ®Google Scholar